*	OR T5 T6
R1	Has_value Arg1:T8 Arg2:T9	
R2	Has_value Arg1:T18 Arg2:T19	
R3	Has_value Arg1:T23 Arg2:T24	
R4	Has_qualifier Arg1:T26 Arg2:T27	
R5	Has_temporal Arg1:T26 Arg2:T28	
R6	Has_index Arg1:T32 Arg2:T33	
R7	Has_value Arg1:T30 Arg2:T31	
R8	Has_temporal Arg1:T30 Arg2:T32	
R9	Has_negation Arg1:T37 Arg2:T38	
R10	Has_index Arg1:T42 Arg2:T43	
R11	Has_value Arg1:T40 Arg2:T41	
R12	Has_temporal Arg1:T40 Arg2:T42	
R13	Has_index Arg1:T49 Arg2:T50	
R14	Has_temporal Arg1:T48 Arg2:T49	
T1	Post-eligibility 0 133	Able to provide voluntary, written informed consent with comprehension of all aspects of the protocol, prior to any study procedures.
T2	Non-query-able 0 133	Able to provide voluntary, written informed consent with comprehension of all aspects of the protocol, prior to any study procedures.
T3	Condition 143 148	obese
T4	Condition 135 142	Healthy
T5	Person 149 153	male
T6	Person 158 164	female
T7	Grammar_Error 154 157	and
T8	Person 176 180	aged
T9	Value 181 206	18 to 55 years, inclusive
T10	Condition 208 220	Heterozygous
T11	Context_Error 208 220	Heterozygous
T12	Value 237 261	18 to 65 years inclusive
T13	Parsing_Error 208 262	Heterozygous subjects may be 18 to 65 years inclusive.
T14	Condition 267 286	good general health
T15	Undefined_semantics 264 393	In good general health, without significant medical history, physical examination findings, or clinical laboratory abnormalities.
T16	Context_Error 264 393	In good general health, without significant medical history, physical examination findings, or clinical laboratory abnormalities.
T17	Subjective_judgement 264 393	In good general health, without significant medical history, physical examination findings, or clinical laboratory abnormalities.
T18	Measurement 395 410	Body Mass Index
T19	Value 414 436	30-40 kg/m2, inclusive
T20	Condition 438 450	Heterozygous
T21	Context_Error 438 450	Heterozygous
T22	Condition 505 517	heterozygous
T23	Measurement 538 541	BMI
T24	Value 542 566	27 -55 kg/ m2, inclusive
T25	Parsing_Error 438 567	Heterozygous subjects may have a broader BMI range; to be eligible heterozygous subjects may have a BMI 27 -55 kg/ m2, inclusive.
T26	Measurement 576 587	body weight
T27	Qualifier 569 575	Stable
T28	Temporal 588 616	during the previous 6 months
T29	Subjective_judgement 618 648	based on Investigator judgment
T30	Measurement 651 665	Blood pressure
T31	Value 666 678	<140/90 mmHg
T32	Temporal 679 699	at Screening and D-1
T33	Reference_point 682 699	Screening and D-1
T34	Parsing_Error 701 777	Measurement may be repeated within 24 hours, based on Investigator judgment.
T35	Subjective_judgement 701 777	Measurement may be repeated within 24 hours, based on Investigator judgment.
T36	Non-query-able 701 777	Measurement may be repeated within 24 hours, based on Investigator judgment.
T37	Condition 799 807	pregnant
T38	Negation 792 795	not
T39	Person 779 786	Females
T40	Measurement 833 853	serum pregnancy test
T41	Value 824 832	negative
T42	Temporal 861 894	at the Screening Visit and Day -1
T43	Reference_point 864 894	the Screening Visit and Day -1
T44	Post-eligibility 779 895	Females must not be pregnant and must have a negative serum pregnancy test result at the Screening Visit and Day -1.
T45	Condition 908 930	childbearing potential
T46	Non-query-able 897 1194	Females of childbearing potential must agree to be abstinent or else use any two of the following medically acceptable forms of contraception from the Screening Period through the Final Study Visit: hormonal, condom with spermicidal jelly, diaphragm or cervical cap with spermicidal jelly, or IUD.
T47	Post-eligibility 897 1194	Females of childbearing potential must agree to be abstinent or else use any two of the following medically acceptable forms of contraception from the Screening Period through the Final Study Visit: hormonal, condom with spermicidal jelly, diaphragm or cervical cap with spermicidal jelly, or IUD.
T48	Procedure 1195 1217	Hormonal contraception
T49	Temporal 1236 1272	at least 3 months prior to screening
T50	Reference_point 1263 1272	screening
T51	Post-eligibility 1274 1398	A female whose male partner has had a vasectomy must agree to use one additional form of medically acceptable contraception.
T52	Post-eligibility 1399 1519	Subjects must agree to practice the above birth control methods for 30 days from the final visit as a safety precaution.
T53	Non-query-able 1274 1398	A female whose male partner has had a vasectomy must agree to use one additional form of medically acceptable contraception.
T54	Non-query-able 1399 1519	Subjects must agree to practice the above birth control methods for 30 days from the final visit as a safety precaution.
T55	Non-query-able 1521 1831	Females of non-childbearing potential, defined as surgically sterile (status post hysterectomy, bilateral oophorectomy, or bilateral tubal ligation) or post-menopausal for at least 12 months (and confirmed with a screening FSH level in the post-menopausal range), do not require contraception during the study.
T56	Post-eligibility 1521 1831	Females of non-childbearing potential, defined as surgically sterile (status post hysterectomy, bilateral oophorectomy, or bilateral tubal ligation) or post-menopausal for at least 12 months (and confirmed with a screening FSH level in the post-menopausal range), do not require contraception during the study.
T57	Non-query-able 1833 2084	Males with female partners of childbearing potential must agree to use two medically acceptable forms of contraception as described above, with one of the two forms being condom with spermicide, from the Screening Period through the Final Study Visit.
T58	Post-eligibility 1833 2084	Males with female partners of childbearing potential must agree to use two medically acceptable forms of contraception as described above, with one of the two forms being condom with spermicide, from the Screening Period through the Final Study Visit.
T59	Non-query-able 2085 2271	Males with female partners of childbearing potential who themselves are surgically sterile (status post vasectomy) must agree to use condoms with spermicide over the same period of time.
T60	Post-eligibility 2085 2271	Males with female partners of childbearing potential who themselves are surgically sterile (status post vasectomy) must agree to use condoms with spermicide over the same period of time.
T61	Post-eligibility 2272 2397	Male subjects must agree to practice the above birth control methods for 30 days from the final visit as a safety precaution.
T62	Non-query-able 2272 2397	Male subjects must agree to practice the above birth control methods for 30 days from the final visit as a safety precaution.
